Ostatní
Návod 
Artivion, Inc.
AORT
Souhrn
Výkazy
Ukazatele
Profil
Držitelé
Návštěvnost webu
Konkurence
Zprávy společnosti
Kapitalizace
2.1B
Obrat
0B
Zisk
0B
Aktiva
1B
Dluh
0B
ROE
0%
ROA
0%
PE
179
PS
4
Cena 1R
22-48
⌀ Cena
37.00
Dividenda
0.0(0.0%)
Čtvrtletní 10-Q
Celoroční 10-K
Nadcházející oznámení zisků
23-02-2026
Poslední dividenda
Profil
Artivion Inc. vyrábí, zpracovává a distribuuje zdravotnické prostředky a implantabilní lidské tkáně po celém světě. Společnost nabízí BioGlue, polymer skládající se z hovězího krevního proteinu a činidla pro zkřížené bílkoviny pro srdeční, cévní, neurologické a plicní procedury; služby konzervace srdce; PhotoFix, hovězí perikardiální náplast; a E-vita Open Plus a E-vita Open Neo. Poskytuje také E-xtra konstrukční inženýrské systémy pro léčbu aortálních cévních onemocnění; E-nside, off-the-shelf stent štěp pro léčbu thorako-břišní choroby; E-vita THORACIC 3G pro endovaskulární léčbu aneurysmat hrudních aort; E-nya, systém hrudního stentu pro minimálně invazivní opravu lézí klesající aorty; E-ventus BX, balónem rozšiřitelný periferní stent štěpu pro endovaskulární léčbu renálních a pánevních artritid E-liac k léčbě aneurysmálních iliakálních artérií a aneurysmálních iliakálních postranních větví; a E-tegra, systém štěpu břišní aorty. Kromě toho společnost nabízí syntetické cévní štěpy pro použití při operacích otevřených aortálních a periferních cév; PerClot, absorbovatelný práškový hemostat pro použití při chirurgických zákrocích; přípravky pro léčbu anginy; CryoVein femorální žíla a CryoArtery femorální arterie cévní konzervační služby; On-X protetické aortální a mitrální srdeční chlopně a On-X ascending aortic prosthesis; CarbonAid CO2 difuzní katéry a Chord-X ePTFE sutury pro mitrální chordální náhrada; a ascyrus medicinální pitevní stenty, stejně jako pyrolytické povlakování uhlíku služby pro výrobce zdravotnických prostředků. Slouží lékařům, nemocnicím a dalším zdravotnickým zařízením, stejně jako kardiochirurgům, vaskulárním, hrudním a všeobecným chirurgům. Společnost byla dříve známá jako CryoLife, Inc. a v lednu 2022 změnila svůj název na Artivion Inc. Společnost byla založena v roce 1984 a sídlí v Kennesaw v Georgii.
Sektor
Healthcare
Odvětví
Medical - Devices
Počet zaměstnanců
1600
Založení
1993-02-12
Podobné společnosti
$ 83.71
+ $ 1.92
$ 68.57
+ $ 0.31
$ 31.23
- $ 0.69
$ 10.16
+ $ 0.73
$ 110.71
- $ 2.37
$ 27.10
+ $ 1.01
$ 6.21
- $ 0.09
Zahraniční články
Výsledovka
Rozvaha
Peněžní toky
Výsledovka
Výsledovka
Rozvaha
Peněžní toky
V miliónech (USD)
| Revenue | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenues | 441.3 | 441.3 | 388.5 | 354.0 | 313.8 | 298.8 | 253.2 | 276.2 | 262.8 | 189.7 | 180.4 | 145.9 | 144.6 | 140.8 | 131.7 | 119.6 | 116.6 | |
| Cost of Revenues | 160.6 | 170.9 | 139.8 | 124.8 | 111.3 | 101.3 | 85.4 | 93.2 | 89.9 | 61.1 | 61.5 | 55.2 | 53.4 | 50.4 | 46.7 | 43.8 | 48.3 | |
| Gross Profit | 280.7 | 270.5 | 248.8 | 229.2 | 202.5 | 197.5 | 167.8 | 183.0 | 173.0 | 128.6 | 118.9 | 90.7 | 91.3 | 90.4 | 85.0 | 75.8 | 68.4 |
| Revenue | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenues | 116.0 | 113.4 | 113.0 | 99.0 | 97.3 | 95.8 | 98.0 | 97.4 | 93.7 | 87.9 | |
| Cost of Revenues | 46.3 | 39.0 | 39.9 | 35.4 | 35.8 | 34.8 | 34.7 | 34.5 | 32.6 | 31.6 | |
| Gross Profit | 69.7 | 74.4 | 73.1 | 63.6 | 61.5 | 61.0 | 63.3 | 62.9 | 61.1 | 56.3 |
| Operating Income | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expenses | 0.0 | 0.0 | 0.0 | 28.7 | 38.9 | 35.5 | 24.2 | 23.0 | 23.1 | 19.5 | 13.4 | 10.4 | 8.7 | 8.5 | 7.3 | 6.9 | 5.9 | |
| Selling General & Admin Expenses | 0.0 | 0.0 | 0.0 | 209.0 | 157.4 | 169.8 | 141.1 | 143.0 | 140.6 | 101.2 | 91.5 | 74.9 | 73.8 | 68.1 | 65.1 | 57.3 | 49.1 | |
| Depreciation & Amortization | 22.5 | 22.5 | 24.2 | 23.1 | 22.4 | 24.0 | -2.9 | 18.3 | 18.1 | 9.7 | 8.4 | 5.9 | 6.0 | 5.8 | 5.6 | 5.0 | 3.9 | |
| Total Operating Expenses | 250.5 | 243.7 | 209.9 | 223.4 | 196.3 | 205.3 | 165.3 | 166.0 | 163.7 | 120.7 | 105.0 | 85.4 | 82.5 | 76.6 | 72.4 | 64.2 | 55.0 | |
| Operating Income | 30.2 | 26.7 | 38.9 | 5.7 | 3.2 | -13.9 | 2.4 | -1.8 | 9.3 | 8.0 | 21.8 | 5.4 | 8.8 | 13.8 | 12.6 | 11.6 | 9.9 |
| Operating Income | TTM | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expenses | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 7.6 | 6.4 | ||
| Selling General & Admin Expenses | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 50.3 | 51.1 | ||
| Depreciation & Amortization | 5.8 | 5.7 | 5.5 | 5.4 | 6.3 | 6.1 | 5.9 | 5.9 | 5.8 | 5.8 | ||
| Total Operating Expenses | 62.5 | 61.9 | 64.7 | 61.4 | 58.8 | 56.6 | 56.8 | 37.6 | 57.9 | 57.5 | ||
| Operating Income | 7.2 | 12.5 | 8.4 | 2.1 | 2.7 | 4.4 | 6.5 | 25.3 | 3.2 | -1.2 |
| Net Income | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Interest Income | 0.8 | 0.8 | 1.5 | 1.1 | 0.1 | 0.1 | 0.2 | 0.7 | 0.2 | 0.2 | 0.1 | 0.1 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Interest Expense | 26.6 | 26.6 | 34.3 | 25.3 | 18.2 | 16.9 | 16.7 | 14.9 | 15.8 | 4.9 | 3.0 | 0.1 | 0.2 | 0.1 | 0.2 | 0.1 | 0.2 | |
| Other Expense | -15.5 | -12.0 | -46.4 | -27.3 | -18.2 | -1.0 | -19.6 | 3.4 | -0.1 | 0.3 | 7.5 | 0.4 | 0.0 | 9.5 | -0.4 | 0.0 | -5.9 | |
| IBT | 14.8 | 14.8 | -7.5 | -21.6 | -15.0 | -14.8 | -17.2 | 1.6 | -6.4 | 3.6 | 18.4 | 5.9 | 8.7 | 23.3 | 12.1 | 11.5 | 7.3 | |
| Income Tax Expense | 5.0 | 5.0 | 5.8 | 9.1 | 4.2 | 0.0 | -0.5 | -0.1 | -2.6 | -0.1 | 7.6 | 1.9 | 1.4 | 7.1 | 4.1 | 4.1 | 3.3 | |
| Net Income | 9.8 | 9.8 | -13.4 | -30.7 | -19.2 | -14.8 | -16.7 | 1.7 | -3.8 | 3.7 | 10.8 | 4.0 | 7.3 | 16.2 | 7.9 | 7.4 | 3.9 |
| Net Income | TTM | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Interest Income | 0.3 | 0.2 | 0.1 | 0.1 | 0.4 | 0.4 | 0.4 | 0.4 | 0.4 | 0.3 | ||
| Interest Expense | 5.5 | 6.1 | 7.3 | 7.7 | 9.7 | 8.4 | 8.3 | 7.8 | 6.2 | 6.6 | ||
| Other Expense | -0.6 | -5.5 | -4.9 | -4.4 | -19.3 | -5.7 | -8.9 | -12.5 | -3.8 | -8.2 | ||
| IBT | 6.5 | 7.1 | 3.5 | -2.3 | -16.6 | -1.3 | -2.4 | 12.8 | -0.6 | -9.4 | ||
| Income Tax Expense | 4.1 | 0.6 | 2.1 | -1.8 | -0.1 | 1.0 | -0.3 | 5.2 | 3.4 | 0.4 | ||
| Net Income | 2.4 | 6.5 | 1.3 | -0.5 | -16.5 | -2.3 | -2.1 | 7.5 | -4.0 | -9.8 |
| Per Share Data | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS | $0.00 | $0.00 | $0.00 | $-0.75 | $-0.48 | $-0.38 | $-0.44 | $0.05 | $-0.10 | $0.11 | $0.33 | $0.14 | $0.26 | $0.59 | $0.29 | $0.26 | $0.14 | |
| EPS Diluted | $0.00 | $0.00 | $0.00 | $-0.75 | $-0.48 | $-0.38 | $-0.44 | $0.05 | $-0.10 | $0.11 | $0.32 | $0.14 | $0.25 | $0.57 | $0.28 | $0.26 | $0.14 | |
| Shares Outstanding | 47.6 | 45.3 | 41.7 | 40.7 | 40.0 | 39.0 | 37.9 | 37.1 | 36.4 | 33.0 | 31.9 | 27.7 | 27.4 | 26.9 | 27.0 | 27.4 | 28.0 | |
| Diluted Shares Outstanding | 49.6 | 47.2 | 41.7 | 40.7 | 40.0 | 39.0 | 37.9 | 37.9 | 36.4 | 34.2 | 32.8 | 28.5 | 28.3 | 27.7 | 27.4 | 27.8 | 28.3 |
| Per Share Data | TTM | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $-0.10 | $-0.24 | ||
| EPS Diluted | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $-0.10 | $-0.24 | ||
| Shares Outstanding | 47.6 | 47.2 | 44.3 | 42.2 | 41.9 | 41.8 | 41.7 | 41.3 | 40.9 | 40.9 | ||
| Diluted Shares Outstanding | 49.6 | 48.8 | 45.4 | 42.2 | 41.9 | 41.8 | 41.7 | 47.9 | 40.9 | 40.9 |
| Current Assets | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash And Equivalents | 55.0 | 53.5 | 58.9 | 39.4 | 55.0 | 62.0 | 34.3 | 41.5 | 40.8 | 57.3 | 43.4 | 33.4 | 43.0 | 18.3 | 21.7 | 35.5 | |
| Short Term Investments | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Total Cash & ST Investments | 55.0 | 53.5 | 58.9 | 39.4 | 55.0 | 62.0 | 34.3 | 41.5 | 40.8 | 57.3 | 43.4 | 33.4 | 43.0 | 18.3 | 21.7 | 35.5 | |
| Accounts Receivable | 79.0 | 85.9 | 74.1 | 69.6 | 58.1 | 48.8 | 55.9 | 51.4 | 51.4 | 30.1 | 26.7 | 22.9 | 18.3 | 16.5 | 15.8 | 14.3 | |
| Inventory | 80.8 | 79.8 | 82.0 | 74.5 | 77.0 | 73.0 | 53.1 | 45.5 | 46.7 | 26.3 | 14.6 | 12.7 | 9.8 | 10.6 | 7.3 | 6.4 | |
| Other Current Assets | 19.5 | 71.0 | 65.6 | 17.6 | 57.6 | 50.8 | 44.2 | 40.8 | 41.2 | 34.2 | 30.8 | 37.1 | 40.6 | 37.4 | 1.7 | 40.8 | |
| Total Current Assets | 234.3 | 290.1 | 280.7 | 247.3 | 247.7 | 234.6 | 187.4 | 179.2 | 179.3 | 147.2 | 109.7 | 106.0 | 106.3 | 77.5 | 83.9 | 93.1 |
| Current Assets | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash And Equivalents | 73.4 | 53.5 | 37.7 | 53.5 | 56.2 | 55.0 | 51.1 | 58.9 | 53.5 | 48.8 | |
| Short Term Investments | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Total Cash & ST Investments | 73.4 | 53.5 | 37.7 | 53.5 | 56.2 | 55.0 | 51.1 | 58.9 | 53.5 | 48.8 | |
| Accounts Receivable | 97.4 | 101.3 | 95.8 | 85.9 | 78.0 | 79.0 | 76.6 | 74.1 | 68.3 | 69.3 | |
| Inventory | 90.5 | 86.7 | 81.9 | 79.8 | 84.1 | 80.8 | 81.7 | 82.0 | 78.8 | 78.5 | |
| Other Current Assets | 22.4 | 77.4 | 71.9 | 71.0 | 69.7 | 70.2 | 67.4 | 31.6 | 66.6 | 67.4 | |
| Total Current Assets | 283.8 | 318.8 | 287.3 | 290.1 | 288.0 | 285.0 | 276.8 | 230.9 | 267.1 | 263.9 |
| Long-Term Assets | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Property, Plant & Equipment | 79.1 | 76.1 | 82.2 | 80.5 | 83.2 | 51.6 | 54.1 | 31.0 | 33.6 | 18.5 | 11.5 | 12.0 | 12.2 | 11.7 | 12.3 | 13.1 | |
| Goodwill | 244.0 | 241.0 | 247.3 | 243.6 | 250.0 | 260.1 | 186.7 | 188.8 | 188.3 | 78.3 | 11.4 | 11.4 | 11.4 | 11.4 | 4.2 | 0.0 | |
| Intangible Assets | 164.4 | 156.4 | 172.2 | 182.6 | 201.5 | 227.1 | 157.7 | 160.1 | 179.4 | 66.6 | 19.9 | 21.3 | 21.9 | 24.1 | 20.4 | 8.9 | |
| Long-Term Investments | 135.2 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 2.0 | 0.0 | 0.0 | 0.0 | 2.0 | 5.9 | 11.2 | -28.6 | |
| Other Long-Term Assets | -70.7 | 24.5 | 8.9 | 7.3 | 8.3 | 14.6 | 14.2 | 7.9 | 7.5 | 5.5 | 10.6 | 9.8 | 4.0 | 10.1 | 2.6 | 41.7 | |
| Total Long-Term Assets | 555.3 | 499.0 | 511.7 | 515.5 | 545.4 | 554.8 | 418.3 | 391.9 | 412.4 | 168.9 | 71.5 | 70.1 | 68.4 | 79.7 | 64.0 | 44.3 | |
| Total Assets | 789.5 | 789.1 | 792.4 | 762.8 | 793.1 | 789.4 | 605.7 | 571.1 | 591.7 | 316.1 | 181.2 | 176.2 | 174.7 | 157.2 | 147.9 | 137.4 |
| Long-Term Assets | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Property, Plant & Equipment | 79.6 | 79.8 | 77.0 | 76.1 | 79.5 | 79.1 | 80.3 | 82.2 | 80.8 | 79.2 | |
| Goodwill | 254.0 | 253.8 | 245.1 | 241.0 | 248.7 | 244.0 | 245.0 | 247.3 | 242.9 | 245.6 | |
| Intangible Assets | 156.8 | 158.4 | 151.9 | 156.4 | 164.6 | 164.4 | 168.0 | 172.2 | 172.1 | 177.0 | |
| Long-Term Investments | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 172.2 | 0.0 | 0.0 | |
| Other Long-Term Assets | 82.8 | 26.9 | 25.0 | 24.5 | 20.9 | 13.8 | 13.3 | -113.5 | 8.2 | 8.2 | |
| Total Long-Term Assets | 573.9 | 519.6 | 499.7 | 499.0 | 515.2 | 504.6 | 507.2 | 561.5 | 507.7 | 514.0 | |
| Total Assets | 857.7 | 838.4 | 791.2 | 789.1 | 803.1 | 789.5 | 784.0 | 792.4 | 774.8 | 777.9 |
| Current Liabilities | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | 11.7 | 18.0 | 13.3 | 12.0 | 10.4 | 9.6 | 9.8 | 7.5 | 9.8 | 5.7 | 4.6 | 4.5 | 4.1 | 3.8 | 4.4 | 4.2 | |
| Short-Term Debt | 4.2 | 5.3 | 5.4 | 5.4 | 5.3 | 7.6 | 7.2 | 1.9 | 1.3 | 4.6 | 0.0 | 0.0 | 14.1 | 14.0 | 13.1 | 10.9 | |
| Other Current Liabilities | 32.9 | 40.6 | 35.3 | 7.7 | 1.1 | 19.2 | 1.8 | 22.8 | 2.4 | 1.1 | 15.0 | 16.1 | 2.2 | 2.2 | 2.1 | 2.1 | |
| Current Liabilities | 50.6 | 66.8 | 57.9 | 49.7 | 45.0 | 60.5 | 45.2 | 34.5 | 42.9 | 30.1 | 19.6 | 20.6 | 20.7 | 21.4 | 21.5 | 19.3 |
| Current Liabilities | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | 16.5 | 19.4 | 11.7 | 18.0 | 11.1 | 11.7 | 10.4 | 13.3 | 10.8 | 10.5 | |
| Short-Term Debt | 5.8 | 5.7 | 5.4 | 5.3 | 104.2 | 4.2 | 3.5 | 5.4 | 6.0 | 6.1 | |
| Other Current Liabilities | 63.5 | 38.7 | 33.3 | 40.6 | 34.0 | 32.9 | 29.9 | 35.3 | 28.7 | 29.0 | |
| Current Liabilities | 85.8 | 66.7 | 51.9 | 66.8 | 152.8 | 50.6 | 45.8 | 57.9 | 55.0 | 56.2 |
| Long-Term Liabilities | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Long-Term Debt | 313.3 | 357.0 | 352.9 | 351.4 | 356.7 | 309.8 | 237.9 | 221.7 | 225.1 | 67.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Capital Leases | 45.2 | 47.9 | 51.4 | 48.7 | 52.9 | 25.7 | 29.4 | 6.7 | 7.4 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Def. Tax Liability | 21.7 | 20.2 | 21.9 | 24.5 | 28.8 | 34.7 | 25.8 | 27.3 | 30.4 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Total Liabilities | 494.5 | 512.9 | 510.6 | 478.5 | 492.3 | 460.7 | 320.0 | 296.0 | 312.6 | 107.2 | 25.9 | 27.5 | 29.9 | 29.0 | 26.3 | 251.4 |
| Long-Term Liabilities | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Long-Term Debt | 256.2 | 258.0 | 357.0 | 357.0 | 258.9 | 358.5 | 359.1 | 352.9 | 352.0 | 349.5 | |
| Capital Leases | 0.0 | 48.1 | 47.6 | 47.9 | 49.1 | 48.5 | 49.3 | 47.4 | 50.1 | 47.5 | |
| Def. Tax Liability | 21.9 | 23.5 | 21.5 | 20.2 | 18.5 | 21.7 | 22.3 | 21.9 | 19.5 | 19.5 | |
| Total Liabilities | 419.0 | 418.5 | 496.9 | 512.9 | 498.4 | 494.5 | 489.0 | 510.6 | 502.8 | 495.4 |
| Total Common Equity | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | 0.4 | 0.4 | 0.4 | 0.4 | 0.4 | 0.4 | 0.4 | 0.4 | 0.4 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | |
| Retained Earnings | -42.5 | -61.3 | -47.9 | -17.2 | 2.0 | 20.0 | 36.7 | 35.0 | 37.6 | 34.1 | 23.4 | 22.8 | 18.7 | 5.5 | -1.0 | -8.4 | |
| Comprehensive Income | -15.9 | -24.9 | -12.0 | -21.6 | -9.9 | 6.7 | -8.6 | -6.1 | 1.9 | -0.4 | -0.1 | -0.1 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Total Common Equity | 295.1 | 276.2 | 281.8 | 284.3 | 300.7 | 328.7 | 285.7 | 275.1 | 279.0 | 209.0 | 155.3 | 148.7 | 144.7 | 128.1 | 121.5 | -113.9 |
| Total Common Equity | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | 0.5 | 0.5 | 0.4 | 0.4 | 0.4 | 0.4 | 0.4 | 0.4 | 0.4 | 0.4 | |
| Retained Earnings | -53.9 | -60.4 | -61.8 | -61.3 | -44.8 | -42.5 | -40.4 | -47.9 | -43.9 | -34.1 | |
| Comprehensive Income | -2.3 | -2.8 | -18.6 | -24.9 | -9.5 | -15.9 | -13.5 | -12.0 | -21.2 | -16.2 | |
| Total Common Equity | 438.7 | 419.9 | 294.3 | 276.2 | 304.7 | 295.1 | 295.0 | 281.8 | 272.0 | 282.5 |
| Other | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Debt | 362.6 | 362.3 | 358.3 | 356.8 | 362.0 | 317.4 | 245.2 | 223.5 | 226.4 | 71.6 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Book Value | 295.1 | 276.2 | 281.8 | 284.3 | 300.7 | 328.7 | 285.7 | 275.1 | 279.0 | 209.0 | 155.3 | 148.7 | 144.7 | 128.1 | 121.5 | -113.9 |
| Other | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Debt | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Book Value | 438.7 | 419.9 | 294.3 | 276.2 | 304.7 | 295.1 | 295.0 | 281.8 | 272.0 | 282.5 |
| Cash Flow From Operating Activities | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | -8.3 | 9.8 | -13.4 | -30.7 | -19.2 | -14.8 | -16.7 | 1.7 | -2.8 | 3.7 | 10.8 | 4.0 | 7.3 | 16.2 | 7.9 | 7.4 | 3.9 | |
| Depreciation & Amortization | 23.4 | 22.5 | 24.2 | 23.1 | 22.4 | 24.0 | 20.7 | 18.3 | 18.1 | 9.7 | 8.4 | 5.9 | 6.0 | 5.8 | 5.6 | 5.0 | 3.9 | |
| Stock-Based Compensation | 14.9 | 24.4 | 14.2 | 14.4 | 12.3 | 10.7 | 6.9 | 8.8 | 6.3 | 6.9 | 6.3 | 5.1 | 3.4 | 3.2 | 3.2 | 2.8 | 2.6 | |
| Change Working Capital | -29.1 | -22.2 | -17.2 | -16.2 | -25.9 | -33.2 | -26.7 | -19.4 | -10.0 | -10.9 | -0.1 | -7.9 | -8.5 | -1.6 | -0.3 | -1.2 | 4.1 | |
| Change In Accounts Receivable | -11.2 | -7.3 | -15.4 | -4.1 | -13.3 | -11.6 | 9.9 | -3.4 | -5.9 | -7.3 | 4.1 | -3.8 | -4.6 | -1.6 | 1.4 | -2.2 | 0.2 | |
| Change In Accounts Payable | -6.0 | 2.2 | 9.5 | 1.7 | -2.0 | -1.9 | -9.2 | 0.3 | -8.9 | 8.7 | 4.7 | -0.7 | -0.1 | 0.6 | 0.5 | -0.8 | 2.4 | |
| Change In Inventories | -9.6 | -15.3 | -6.1 | -14.4 | -8.4 | -18.4 | -24.8 | -8.1 | 2.4 | -9.4 | -9.5 | -2.3 | -1.1 | 0.2 | -1.6 | 2.4 | -1.8 | |
| Other Non-cash Items | 45.9 | 3.6 | 15.9 | 29.6 | 6.9 | 15.3 | 23.8 | 8.7 | 2.8 | 2.8 | -6.3 | 0.7 | -0.3 | -7.5 | 1.3 | 1.0 | 7.7 | |
| Cash from Operations | 8.5 | 0.0 | 0.0 | 18.8 | -5.2 | -2.6 | 12.4 | 15.8 | 9.9 | 10.8 | 19.7 | 11.4 | 8.1 | 16.8 | 19.0 | 16.8 | 20.8 |
| Cash Flow From Operating Activities | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | 2.4 | 6.5 | 1.3 | -0.5 | -16.5 | -2.3 | -2.1 | 7.5 | -4.0 | -9.8 | |
| Depreciation & Amortization | 5.8 | 5.7 | 5.5 | 5.4 | 6.3 | 6.1 | 5.9 | 5.9 | 5.8 | 5.8 | |
| Stock-Based Compensation | 0.0 | 0.0 | 0.0 | 8.0 | 2.7 | 0.0 | 4.3 | 3.5 | 4.0 | 3.2 | |
| Change Working Capital | 2.2 | 3.2 | -0.9 | -26.8 | 0.9 | 1.7 | -3.7 | -16.2 | -6.3 | -3.0 | |
| Change In Accounts Receivable | -6.3 | 8.7 | -1.7 | -7.9 | -12.0 | 3.1 | -3.1 | -3.3 | -4.8 | 0.1 | |
| Change In Accounts Payable | 9.4 | -1.0 | 9.8 | -16.1 | 14.7 | 0.8 | 3.2 | -9.2 | 1.3 | -1.2 | |
| Change In Inventories | -3.7 | -6.0 | -3.1 | -2.5 | -1.3 | -2.6 | -0.8 | -1.4 | -3.8 | -3.7 | |
| Other Non-cash Items | 7.6 | 6.3 | 9.2 | -3.2 | 14.0 | 11.1 | 5.1 | -10.5 | 5.2 | 10.2 | |
| Cash from Operations | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 10.6 | 7.2 |
| Cash Flow From Investing Activities | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Capital Expenditure | -9.5 | -39.0 | -11.2 | -7.4 | -10.7 | -13.1 | -7.3 | -8.1 | -5.8 | -7.0 | -7.4 | -4.1 | -5.3 | -4.3 | -3.1 | -2.5 | -7.5 | |
| Acquisitions | -14.3 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -59.1 | 0.0 | 0.0 | -163.9 | -71.4 | -1.3 | 0.2 | 0.0 | -17.0 | -21.1 | 0.0 | |
| Investments | -5.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -1.0 | -1.0 | -1.1 | -1.2 | 0.0 | 0.0 | -3.6 | -2.4 | |
| Sales of Investment | 14.3 | 0.0 | 0.0 | 0.0 | 0.0 | 19.0 | 0.0 | 0.0 | 0.0 | 1.0 | 1.1 | 2.0 | 1.2 | 15.4 | 0.0 | 0.0 | 0.0 | |
| Other Investing Activities | 3.7 | 0.0 | 0.0 | 6.9 | 0.0 | -0.2 | -6.7 | -15.9 | -0.9 | -0.1 | 4.9 | 0.0 | -0.2 | -0.2 | -2.8 | -0.5 | -0.8 | |
| Cash from Investing | -10.9 | 0.0 | 0.0 | -0.5 | -10.7 | 5.7 | -73.1 | -23.9 | -6.7 | -171.0 | -73.9 | -4.5 | -5.4 | 10.9 | -22.9 | -27.7 | -10.7 |
| Cash Flow From Investing Activities | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Capital Expenditure | -27.5 | -4.6 | -3.3 | -3.6 | -1.4 | -3.6 | -2.5 | -3.6 | -1.9 | -1.5 | |
| Acquisitions | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -14.3 | 0.0 | |
| Investments | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -5.0 | 0.0 | |
| Sales of Investment | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 14.3 | 0.0 | |
| Other Investing Activities | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 4.3 | -0.6 | |
| Cash from Investing | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -2.7 | -2.1 |
| Cash Flow From Financing Activities | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt Repaid | -10.8 | 0.0 | 0.0 | -2.8 | -2.8 | -3.1 | -35.3 | -2.8 | -2.8 | -72.2 | -1.4 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -1.5 | |
| Debt Issued | 18.3 | 362.3 | 3.9 | 4.3 | -2.5 | 47.8 | 107.6 | 24.4 | -0.1 | 227.0 | 73.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 1.5 | |
| Issuance of Common Stock | 5.0 | 0.0 | 0.0 | 0.0 | 3.4 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Repurchase of Common Stock | 0.0 | 0.0 | 0.0 | -0.6 | -1.8 | -1.9 | -2.0 | -2.7 | -2.1 | -1.6 | -0.7 | -1.4 | -7.1 | -1.5 | -3.5 | -3.1 | -5.9 | |
| Dividends Paid | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -3.4 | -3.3 | -3.0 | -1.4 | 0.0 | 0.0 | |
| Other Financing Activities | -0.5 | 0.0 | 0.0 | 4.2 | -0.5 | -7.2 | 130.9 | 4.0 | 2.3 | 217.1 | 75.5 | 2.0 | 3.4 | 1.4 | 0.2 | 0.2 | 2.7 | |
| Cash from Financing | 8.3 | 0.0 | 0.0 | 0.9 | -1.6 | -12.2 | 93.6 | -1.5 | -2.6 | 143.2 | 73.4 | -2.8 | -7.0 | -3.1 | -4.7 | -2.8 | -4.7 |
| Cash Flow From Financing Activities | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt Repaid | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -1.7 | -1.7 | |
| Debt Issued | 262.0 | -1.8 | -98.6 | 0.1 | -0.9 | 0.5 | 0.0 | 3.3 | 3.6 | 4.0 | |
| Issuance of Common Stock | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.9 | |
| Repurchase of Common Stock | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Dividends Paid | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Other Financing Activities | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | 0.8 | |
| Cash from Financing | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -1.4 | -0.9 |
| Cash position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Change in Cash | 6.2 | 11.4 | -5.5 | 19.6 | -15.7 | -6.9 | 27.7 | -7.9 | 1.5 | -16.7 | 19.1 | 4.2 | -4.3 | 24.6 | -8.7 | -13.8 | 5.4 | |
| Closing Cash Balance | 55.0 | 64.9 | 53.5 | 58.9 | 39.4 | 55.0 | 62.0 | 34.3 | 42.2 | 40.0 | 56.6 | 37.6 | 33.4 | 37.6 | 13.0 | 21.7 | 35.5 |
| Cash position | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Change in Cash | -8.5 | 20.0 | 15.8 | -15.8 | -2.7 | 1.2 | 3.9 | -7.8 | 5.5 | 4.7 | |
| Closing Cash Balance | 64.9 | 73.4 | 53.5 | 37.7 | 53.5 | 56.2 | 55.0 | 51.1 | 58.9 | 53.5 |
| Free Cash Flow | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -1.1 | -0.9 | 11.0 | 11.4 | -15.9 | -15.7 | 5.0 | 7.8 | 4.1 | 3.8 | 12.3 | 7.3 | 2.8 | 12.4 | 15.9 | 14.2 | 13.3 | |
| Real Free Cash Flow | -15.9 | -25.3 | -3.2 | -3.0 | -28.2 | -26.4 | -1.9 | -1.0 | -2.2 | -3.2 | 6.0 | 2.3 | -0.6 | 9.2 | 12.8 | 11.4 | 10.7 |
| Free Cash Flow | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -7.9 | 15.9 | 11.7 | -20.6 | 8.7 | 7.8 | 3.6 | -9.1 | 8.7 | 5.8 | |
| Real Free Cash Flow | -7.9 | 15.9 | 11.7 | -28.6 | 6.0 | 7.8 | -0.6 | -12.6 | 4.7 | 2.6 |
Nacenění
Finance
Efektivita
Marže
Dividenda
Ostatní
Nacenění
| Ukazatel | Aktuální | Historické | Konkurence |
|---|---|---|---|
| P/E | 179.3 | -155.9 | 179.3 |
| P/S | 4 | 3.2 | 390.6 |
| P/B | 4 | 3.2 | 113.4 |
| P/FCF | -195.6 | -106.3 | 149.9 |
| Market cap | $2.1 | $1.0 |
P/E (Price to Earnings Ratio) – Poměr ceny akcie k zisku za posledních 12 měsíců. Říká, kolik korun investor zaplatí za 1 korunu zisku. Např.: P/E = 15 znamená, že pokud akcie stojí 15 Kč, firma vydělala 1 Kč za poslední rok.
Finance
| Ukazatel | Aktuální | Historické | Srovnání |
|---|---|---|---|
| Debt to Assets | 0 % | 22.6 % | 0 % |
| Debt to Income | 2682.1 % | -1844.9 % | 0 % |
| Debt to Free cash flow | -2925.3 % | 46.2 % | 0 % |
| Interest expense percentage | 87.9 % | 110.3 % | 11.2 % |
| Current ratio | 3.3 | 4.7 | 0 |
Efektivita
| Ukazatel | Aktuální | Historické | Srovnání |
|---|---|---|---|
| ROE | 2.2 % | 0.5 % | 0 % |
| ROA | 1.1 % | 1.3 % | 0 % |
| CapEx to Revenue | 8.8 % | 3.3 % | 6 % |
| RaD to Revenue | 0 % | 7.6 % | 0 % |
| ROEM | 275,831.3 | 259872.4 |
Marže
| Ukazatel | Aktuální | Historické | Srovnání |
|---|---|---|---|
| Gross margin | 63.6 % | 64.3 % | 61.9 % |
| Operating margin | 6.9 % | 6.1 % | 17.9 % |
| Net margin | 2.2 % | 1 % | 13 % |
Dividenda
| Ukazatel | Aktuální | Historické | Srovnání |
|---|---|---|---|
| Dividend yield | 0 % | 0.4 % | 0 % |
| Dividend payout percentage | 0 % | -161 % | 0 % |
Dividend yield (Dividendový výnos) ukazuje aktuální procentuální výnos z dividend vůči ceně akcie.
Ostatní
| Ukazatel | Aktuální | Historické |
|---|---|---|
| Shares outstanding | 49.6 mil | 34.8 mil |
| Employee count | 1.6 tis | 0.6 tis |
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
